KalVista Pharmaceuticals (KALV) Receivables (2017)
KalVista Pharmaceuticals' Receivables history spans 1 years, with the latest figure at $7.3 million for Q4 2017.
- For Q4 2017, Receivables changed N/A year-over-year to $7.3 million; the TTM value through Oct 2017 reached $7.3 million, changed N/A, while the annual FY2017 figure was $7.6 million, N/A changed from the prior year.
- Receivables for Q4 2017 was $7.3 million at KalVista Pharmaceuticals, down from $7.4 million in the prior quarter.
- Across five years, Receivables topped out at $7.6 million in Q2 2017 and bottomed at $7.3 million in Q4 2017.